-
PROVIDERS
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
-
LIFE SCIENCES
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
12/29/2022
Product Theatre Presentation from the 2022 SABCS Annual Meeting
Advancing The Standards Of Breast Cancer Care With Comprehensive Somatic Next-Generation Sequencing, Germline Testing, And AI-Driven Data
Speakers
Cynthia Ma, MD, PhD, Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center
Calvin Chao, MD, Senior Vice President of Medical Affairs at Tempus Labs
Calvin Chao, MD, Senior Vice President of Medical Affairs at Tempus Labs
Hear from Dr. Cynthia Ma of Siteman Cancer Center in St. Louis and Dr. Calvin Chao of Tempus as they discuss how broad panel next generation sequencing (NGS) continues to evolve and expand delivery of personalized solutions within breast cancer care. Dr. Chao discussed Tempus’ comprehensive portfolio of somatic and germline options and how we are fueling research through our multimodal oncology dataset.
This Exhibitor Product Theatre is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Product Theatre and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium® (SABCS®).
-
06/25/2024Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more -
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more